Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Xiang H, She Z, Wang L, Peng Y, et al. Comparison of Atezolizumab plus Aevacizumab and Atezolizumab plus Aabozantinib for advanced hepatocellular carcinoma: A cost-effectiveness analysis. PLoS One 2025;20:e0337606.
PMID: 41335584


Privacy Policy